Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 2NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 2Other hematologic neoplasm 1Head & Neck 1Dermatologic 1Breast 1

Conditions

Uveal Melanoma 1

Interventions

aldesleukin 69Cyclophosphamide 50fludarabine phosphate 36fludarabine 30Interleukin-2 27incomplete Freund's adjuvant 22Ipilimumab 20Biopsy 20Specimen Handling 19Magnetic Resonance Spectroscopy 19MART-1 Antigen 15CTLA-4 Antigen 15sargramostim 14Nivolumab 13Filgrastim 13montanide ISA 51 12Sorafenib 12Interferon-alpha 11pembrolizumab 10trametinib 9Temozolomide 9Bevacizumab 9dabrafenib 8temsirolimus 7Sirolimus 7Gene Expression Profiling 7tanespimycin 6Paclitaxel 6Dacarbazine 6Cisplatin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Reverse Transcriptase Polymerase Chain Reaction × Dermatologic × Clear all
NCT00897624 2011-05-13

Bone Marrow and Blood Samples From Patients With Metastatic Choroid Melanoma

National Cancer Institute (NCI)

Completed
15 enrolled
Dermatologic

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡